rs35861031
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_005732.4(RAD50):c.3716G>A(p.Arg1239Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,614,148 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005732.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RAD50 | NM_005732.4 | c.3716G>A | p.Arg1239Gln | missense_variant | Exon 24 of 25 | ENST00000378823.8 | NP_005723.2 | |
| TH2LCRR | NR_132124.1 | n.45+977C>T | intron_variant | Intron 1 of 2 | ||||
| TH2LCRR | NR_132125.1 | n.189+1429C>T | intron_variant | Intron 2 of 2 | ||||
| TH2LCRR | NR_132126.1 | n.175-2504C>T | intron_variant | Intron 1 of 1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RAD50 | ENST00000378823.8 | c.3716G>A | p.Arg1239Gln | missense_variant | Exon 24 of 25 | 1 | NM_005732.4 | ENSP00000368100.4 | ||
| ENSG00000283782 | ENST00000638452.2 | c.3419G>A | p.Arg1140Gln | missense_variant | Exon 26 of 27 | 5 | ENSP00000492349.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152176Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251452 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461856Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727230 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152292Hom.: 1 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74452 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Nijmegen breakage syndrome-like disorder Uncertain:3
- -
- -
- -
Hereditary cancer-predisposing syndrome Uncertain:2
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1239 of the RAD50 protein (p.Arg1239Gln). This variant is present in population databases (rs35861031, gnomAD 0.03%). This missense change has been observed in individual(s) with breast cancer (PMID: 26689913). ClinVar contains an entry for this variant (Variation ID: 140979). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RAD50 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
The p.R1239Q variant (also known as c.3716G>A), located in coding exon 24 of the RAD50 gene, results from a G to A substitution at nucleotide position 3716. The arginine at codon 1239 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. -
not provided Uncertain:1
The RAD50 c.3716G>A (p.Arg1239Gln) variant has been reported in the published literature in an individual with breast cancer (PMID: 26689913 (2015)). The frequency of this variant in the general population, 0.0003 (3/10080 chromosomes (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is uninformative in the assessment of its pathogenicity. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is benign or damaging. Based on the available information, we are unable to determine the clinical significance of this variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at